What is XG Sciences?
Founded in 2006 and headquartered in Lansing, Michigan, XG Sciences operates at the intersection of material science and industrial application. The company specializes in the production of graphene nanoplatelets, a versatile material that enhances the performance of various end-products, including silicon-graphene lithium-ion battery anodes, high-strength concrete, and advanced 3D printing materials. By focusing on the commercialization of these bulk materials, XG Sciences addresses the growing demand for high-performance, lightweight, and conductive components across the automotive, aerospace, and consumer electronics industries. Their technical expertise in flexural modulus and material integration positions them as a key supplier in the global supply chain for next-generation hardware.
How much funding has XG Sciences raised?
XG Sciences has raised a total of $886K across 2 funding rounds:
Debt
$350K
Debt
$536K
Debt (2020): $350K with participation from PPP
Debt (2021): $536K led by PPP
Key Investors in XG Sciences
PPP
Public-Private Partnership
What's next for XG Sciences?
With the recent capital injection, XG Sciences is well-positioned to transition from a research-heavy entity to a dominant industrial player. The strategic focus will likely shift toward optimizing production efficiency to meet the rigorous demands of the electric vehicle battery market, where silicon-graphene anodes are becoming increasingly vital for energy density improvements. Furthermore, the company is expected to leverage this financing to deepen its research and development efforts in 3D printing, potentially unlocking new revenue streams in industrial prototyping and manufacturing. As the firm scales, maintaining its competitive edge in material purity and cost-effective mass production will be the primary driver for long-term enterprise value and market penetration.
See full XG Sciences company page
